Aptevo Therapeutics Inc (APVO) — Financial Flexibility Index
Aptevo Therapeutics Inc (APVO) has a Financial Flexibility Index of -0.96x as of March 2026. Free cash flow of $-7.96 Million (operating CF $-7.96 Million minus capex $0.00) represents -1% of total liabilities ($8.29 Million). Check APVO strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aptevo Therapeutics Inc Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for Aptevo Therapeutics Inc across 12 annual periods. See Aptevo Therapeutics Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Aptevo Therapeutics Inc (2014–2025)
Year-by-year free cash flow to debt coverage for Aptevo Therapeutics Inc. For the full company profile including market capitalisation, see APVO market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.61x | $-25.59 Million | $-25.59 Million | $9.81 Million | ▼ -18.8% |
| 2024 | -2.19x | $-23.79 Million | $-23.79 Million | $10.84 Million | ▼ -136.2% |
| 2023 | -0.93x | $-11.73 Million | $-11.73 Million | $12.62 Million | ▲ +28.1% |
| 2022 | -1.29x | $-20.99 Million | $-21.02 Million | $16.24 Million | ▼ -241.5% |
| 2021 | -0.38x | $-20.97 Million | $-21.68 Million | $55.38 Million | ▲ +52.1% |
| 2020 | -0.79x | $-29.23 Million | $-29.32 Million | $36.95 Million | ▲ +22.1% |
| 2019 | -1.02x | $-42.23 Million | $-42.38 Million | $41.57 Million | ▲ +25.3% |
| 2018 | -1.36x | $-50.45 Million | $-51.42 Million | $37.09 Million | ▼ -18.4% |
| 2017 | -1.15x | $-40.17 Million | $-41.57 Million | $34.97 Million | ▼ -38.1% |
| 2016 | -0.83x | $-34.35 Million | $-36.86 Million | $41.29 Million | ▲ +58.0% |
| 2015 | -1.98x | $-47.23 Million | $-48.76 Million | $23.84 Million | ▼ -9.2% |
| 2014 | -1.81x | $-46.02 Million | $-47.01 Million | $25.36 Million | — |